Neoangiogenesis in colon cancer: Correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 617-620

  Faviana, P ^a   Boldrini, L ^a   Spisni, R ^a   Berti, P ^a   Galleri, D ^a   Biondi, R ^a   Camacci, T ^a   Materazzi, G ^a   Pingitore, R ^a   Miccoli, P ^a   Fontanini, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Human colon cancer; Microvessels count; p53; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIGEN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PROTEIN P53; VASCULOTROPIN; VASCULOTROPIN A;

AGED; ARTICLE; BIOSYNTHESIS; COLON TUMOR; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MUTATION; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

AGED; ANTIGENS, CD34; COLONIC NEOPLASMS; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036583234     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.3.617     Document Type: Article

References (23)

1. Hanahan D and Folkman J: Patterns of emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996. (Pubitemid 26272076)
2. Auerbach W and Auerbach R: Angiogenesis inhibition: a review. Pharm Ther 63: 265-311, 1994. (Pubitemid 24315751)
3. Tischer E, Gospodarowicz D, Mitchell R, et al: Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 165: 1198-1206, 1989. (Pubitemid 20029835)
4. Leung D, Cachianes G, Kuang W-J, Goeddel D and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989. (Pubitemid 20066716)
5. Keck P, Hauser S, Krivi G, et al: Tumor permeability factor an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989. (Pubitemid 20066717)
6. Berse B, Brown LF, van De Water L, Dvorak HF and Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3: 211-220, 1992. (Pubitemid 23084552)
7. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR and Smith SK: Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87: 506-516, 1995.
8. Fontanini G, Boldrini L, Chinè S, Pisaturo F, Vignati S, Calcinai A, Lucchi M, Mussi A, Basolo F, Angeletti CA and Bevilacqua G: Expression of vascular endothelial growth factor mRNA in non-small cell lung carcinomas. Br J Cancer 79: 363-369, 1999. (Pubitemid 29002309)
9. Brown LF, Berse, B, Jackman RW, Tognazzi K, Manseau EJ and Dvorak HF: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262, 1993. (Pubitemid 24057094)
10. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis: Breast Cancer Res Treat 36: 127-137, 1995.
11. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997. (Pubitemid 27076453)
12. Takahashi Y, Bucana CD, Cleary KR and Ellis LM: p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 79: 34-38, 1998. (Pubitemid 28157723)
13. Mukhopadhyay D, Tsiokas L and Sukhatme V: Wild-type P53 and v-Src opposing influence on human vascular endothelial growth factor gene expression. Cancer Res 57: 6161-6165, 1995.
14. Kieser A, Weich HA, Brandner G, Marmeí D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 964-969, 1994.
15. Fontanini G, Bigini D, Vignati S, Macchiarini P, Pepe S, Angeletti CA, Pingitore R and Squartini F: p53 expression in non-small cell lung cancer: clinical and biological correlations. Anticancer Res 13: 737-742, 1993. (Pubitemid 23216976)
16. Jessup JM, et al: Chromosome 17 deletions and p53 gene mutations in colorectal cancer. Science 244: 217-221, 1989. (Pubitemid 19110302)
17. Ridrigues NR, Rowan A, Smith MEF, Kerr IB, Bodmer WF, Gannon J, et al: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990. (Pubitemid 20341755)
18. Weidner N and Folkman J: Tumoral vascularity as a prognostic factor in cancer. In: Important Advances In Oncology. De Vita VT, Hellmann S and Rosenberg SA (eds). Lippincott-Raven, Philadelphia, pp167-190, 1996.
19. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
20. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD and Ellis LM: Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2: 1679-1684, 1996. (Pubitemid 26356351)
21. Warren RS, Yuan H, Matli MR, Gillett NA and Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797, 1995.
22. Kastan MB, Onyekere O, Sidrensky D, Vogelstein B and Craig RW: Partecipation of p53 protein in the cellular respons to DNA damage. Cancer Res 51: 6304-6311, 1991.
23. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994. (Pubitemid 24289415)